natgillin/translations-raw huggingface dataset:
Cats
Mačke.
Cats
Mačke:
Cats 2.5-7.5 kg
Mačke 2,5 - 7,5 kg
Cats 2.5–7.5 kg
Mačke 2,5 - 7,5 kg
Cats <2.5 kg
Mačke < 2,5 kg
Cats and Dogs
Mačke
Cats and dogs
Mačke i psi.
Cats and Dogs
Mačke, Psi
Cats and dogs from various breeds, age groups and weights were treated.
Liječeni su psi i mačke različitih pasmina, dobnih skupina i težina.
Cats can develop diabetic remission, in which case the cat's own insulin production is regained and insulin dosing will need to be adjusted or ceased.
Mačke mogu razviti dijabetičku remisiju, pri čemu tijelo ponovno uspostavlja proizvodnju vlastitog inzulina te se dozu inzulina treba prilagoditi ili obustaviti.
Cats can develop diabetic remission, in which case the cat's own insulin production is regained.
Mačke mogu razviti dijabetičku remisiju, pri čemu tijelo mačke ponovno uspostavlja proizvodnju vlastitog inzulina.
Cats in endemic areas, or those which have travelled to endemic areas, may be infected with adult heartworms.
Mačke koje žive u područjima gdje je enzootski proširena dirofilarioza ili jedinke koje su putovale u takva područja, mogu biti invadirane odraslim srčanim crvima.
Cats in the household should be treated with a product authorised for use in that species.
Mačke u kućanstvu trebaju biti liječene veterinarsko- medicinskim proizvodom dozvoljenim za primjenu u mačaka.
Cats in the household should be treated with a veterinary medicinal product authorised for use in that species.
Mačke u kućanstvu trebaju biti liječene veterinarsko- medicinskim proizvodom dozvoljenim za primjenu u mačaka.
Cats infected with adult heartworms tolerated up to 3 times the maximum exposure dose (i.e. up to 9 times the recommended dose), every 4 weeks for 3 treatments, without any adverse effects.
Mačke invadirane odraslim oblićima Dirofilaria immitis toleriraju bez ikakvih nuspojava izloženost dozi koja je tri puta veća od maksimalne (tj. do 9 puta veća od preporučene doze) svaka 4 tjedna, 3 tretmana.
Cats infected with adult heartworms tolerated up to 3 times the maximum exposure dose (i.e. up to 9 times the recommended dose), every 4 weeks for 3 treatments, without any adverse effects.
Mačke invadirane odraslim oblićima Dirofilaria immitis toleriraju bez ikakvih nuspojava izloženost dozi koja je tri puta veća od maksimalne (tj. do 9 puta veća od preporučene doze), svaka 4 tjedna, 3 tretmana.
Cats may rarely show a slight scaling of their skin, temporary redness and itching or temporary hair loss at the application site.
Kod mačaka se rijetko može demonstrirati blago razdjeljivanje kože, privremeno crvenilo i svrbež ili privremeni gubitak kose u mjestu primjene.
Cats, ferrets
Mačke, afrički tvorovi
Cats: After administration of 40 micrograms dexmedetomidine/kg bw intramuscularly concurrently with 5 mg ketamine/kg bw to cats, the maximum concentration of dexmedetomidine increased twofold but there was no effect on T max.
Mačke: Nakon istodobne intramuskularne primjene 40 mikrograma deksmedetomidina/kg tjelesne mase i 5 mg ketamina/kg tjelesne mase u mačaka, maksimalna se koncentracija deksmedetomidina povećala dva puta, ali nije bilo utjecaja na T max.
Cats: After administration of 40 micrograms dexmedetomidine/kg bw intramuscularly concurrently with 5 mg ketamine/kg bw to cats, the maximum concentration of dexmedetomidine increased twofold but there was no effect on Tmax.
Mačke: Nakon istodobne intramuskularne primjene 40 mikrograma deksmedetomidina/kg tjelesne mase i 5 mg ketamina/kg tjelesne mase u mačaka, maksimalna se koncentracija deksmedetomidina povećala dva puta, ali nije bilo utjecaja na T max.
Cats: After administration of 40 micrograms dexmedetomidine/kg bw intramuscularly concurrently with 5 mg ketamine/kg bw to cats, the maximum concentration of dexmedetomidine increased twofold but there was no effect on Tmax.
Nakon istodobne intramuskularne primjene 40 mikrograma deksmedetomidina/kg tjelesne mase i 5 mg ketamina/kg tjelesne mase u mačaka, maksimalna se koncentracija deksmedetomidina povećala dva puta, ali nije bilo utjecaja na Tmax.
CATS: In cases of overdosage, or if the effects of dexmedetomidine become potentially life- threatening, the appropriate antagonist is atipamezole, administered by intramuscular injection, at the following dose: 5 times the initial dose dexmedetomidine in micrograms/kg bw.
MAČKE: U slučajevima predoziranja ili ako učinci deksmedetomidina postanu potencijalno životno ugrožavajući, prikladni antagonist je atipamezol, primijenjen intramuskularnom injekcijom u sljedećoj dozi: peterostruka inicijalna doza deksmedetomidina u mikrogramima/kg tjelesne težine.
Cats: intramuscular use
Mačke: intramuskularna primjena
Cats: intramuscular use
Mačke: intramuskularna primjena.
Cats: Post-operative pain: single subcutaneous injection.
Mačke: Poslijeoperacijska bol: jedna supkutana injekcija.
Cats: s.c.
Mačke: s.c.
Cats: SC.
Mačke: s.c.
Cats: single administration of 0.3 mg meloxicam/kg body weight (i.e.
Mačke: jedna primjena od 0,3 mg meloksikama/kg tjelesne mase (tj.
Cats: single administration of 0.3 mg meloxicam/kg body weight (i.e.
Mačke: jedna primjena od 0,3 mg meloksikama/kg tjelesne težine (tj.
Cats: single administration of 0.3 mg meloxicam/kg body weight (i.e.
Mačke: jednokratno davanje 0.3 mg meloksikama / kg tjelesne mase (tj.
Cats: subcutaneous use
mačke: supkutana
Cats: The recommended dose is 25 mg indoxacarb/kg body weight, equivalent to 0.128 ml/kg body weight.
Mačke: Preporučena doza je 25mg indoksakarba/kg tjelesne mase, što je ekvivalent za 0,128 ml/kg tjelesne mase.
Cattle
Goveda.
Cattle
Goveda:
Cattle
Szarvasmarha
Cattle (calves and young cattle) and pigs
Goveda (telad i junad) i svinje
Cattle (calves and young cattle) and pigs.
Goveda (telad i junad) i svinje
Cattle (calves and young cattle) and pigs.
Goveda (telad i mlada goveda) i svinje
Cattle (calves and young cattle) and pigs.
Goveda (telad i mlada goveda) i svinje.
Cattle (cows and heifers)
Stoka (krave muzare i junice)
Cattle (lactating dairy cows)
Goveda (mliječne krave u laktaciji)
Cattle and goats
Goveda i koze.
Cattle and horses.
Goveda i konji
Cattle and horses.
Goveda i konji.
Cattle and pigs.
Goveda i svinje.
Cattle and Pigs: Can be used during pregnancy and lactation.
Goveda i svinje: Može se primjenjivati tijekom graviditeta i laktacije.
Cattle and Sheep
Goveda i ovce
Cattle and sheep: for subcutaneous use.
Goveda i ovce: potkožno.
Cattle and sheep: SC.
Goveda i ovce: s.c.
Cattle Box
Govedo Kutija
Cattle from 2 weeks of age: one dose of 2 ml, by subcutaneous route.
Goveda od 2 tjedna starosti: jedna doza od 2 ml potkožno.
Cattle from 2.5 months of age:
Goveda u dobi od 2,5 mjeseci i više:
Cattle from 6 weeks of age: subcutaneous injection of two doses of 1 ml, administered with an interval of approximately 3 weeks.
Goveda od 6 tjedana starosti: potkožna injekcija dvije doze od 1 ml, u intervalu od otprilike 3 tjedna.
Cattle weighing more than 250 kg and pigs weighing more than 125 kg will need to have the dose divided and injected at more than one site.
Dozu lijeka za goveda koja teže iznad 250 kg i za svinje koje teže iznad 125 kg bit će potrebno podijeliti i injicirati na više mjesta.
Cattle, and horses
Goveda i konji
Cattle, Horse and Pig
Goveda, svinje
Cattle, Horse and Pig
Goveda, svinje i konji
Cattle, horses and pigs
Goveda, svinje i konji
Cattle, pigs
Goveda i svinje
Cattle, pigs and horses
goveda, svinje i konje
Cattle, pigs and sheep
Goveda,svinje i ovce
Cattle, pigs and sheep
Govedo, svinje i ovce
Cattle, pigs, horses
Goveda, svinje, konji.
Cattle, sheep and pigs
Goveda, ovce i svinje
Cattle, sheep, and pigs
Goveda, ovce i svinje
Cattle, sheep: SC.
Govedo, ovce: s.c.
Cattle: Can be used during pregnancy and lactation.
Goveda: može se primijeniti tijekom graviditeta i laktacije.
Cattle: For subcutaneous use.
Goveda: subkutana upotreba.
Cattle: intramuscular use.
Goveda: intramuskularna primjena.
Cattle: intravenous or subcutaneous Pigs: intramuscular
Goveda: supkutana ili intravenska Svinje:
Cattle: intravenous or subcutaneous Pigs: intramuscular
Goveda: supkutana ili intravenska Svinje: intramuskularna
Cattle: Meat and offal: 15 days
Goveda: Meso i jestive iznutrice: 15 dana
Cattle: meat and offal: 15 days.
Goveda: meso i jestive iznutrice: 15 dana
Cattle: meat and offal: 15 days; milk: 5 days
Goveda: meso i jestive iznutrice 15 dana; mlijeko: 5 dana
Cattle: meat and offal: 15 days; milk: 5 days
Goveda: meso i jestive iznutrice: 15 dana; mlijeko: 5 dana
Cattle: meat and offal: 15 days; milk: 5 days Pigs, horses: meat and offal: 5 days
Goveda: meso i jestive iznutrice: 15 dana; mlijeko: 5 dana Svinje, konji: meso i jestive iznutrice: 5 dana
Cattle: Meat and offal: 15 days; Milk: 5 days Pigs: Meat and offal: 5 days
Goveda: Meso i iznutrice: 15 dana; Mlijeko: 5 dana Svinje: Meso i iznutrice: 5 dana
Cattle: meat and offal: 15 days; milk: 5 days.
Goveda: meso i jestive iznutrice 15 dana; mlijeko: 5 dana
Cattle: meat and offal: 15 days; milk: 5 days.
Goveda: meso i jestive iznutrice 15 dana; mlijeko: 5 dana.
Cattle: meat and offal: 15 days; milk: 5 days.
Goveda: meso i jestive iznutrice: 15 dana; mlijeko: 5 dana
Cattle: QI02AA08
Goveda: QI02AA08
Cattle: S.C., I.V.
Goveda: s.c. ili i.v.
Cattle: SC
Goveda: s.c.
Cattle: SC ,IV
Goveda: s.c., i.v.
Cattle: SC injection.
Goveda: s.c. injekcija
Cattle: SC or IV injection.
Goveda: s.c. ili i.v. injekcija
Cattle: SC or IV.
Goveda: s.c. ili i.v.
Cattle: SC, IV
Goveda: potkožno, i.v.
Cattle: SC.
Goveda: s.c.
Cattle: SC.
Govedo: s.c.
Cattle: Single S.C. or I.V. injection.
Goveda: Jedna s.c.ili i.v.injekcija.
Cattle: subcutaneous injection.
Goveda: subkutana injekcija.
Cattle: subcutaneous or intravenous use
Goveda: supkutana ili intravenska
Cattle: Subcutaneous or intravenous use Pigs: Intramuscular use
Goveda: Potkožno ili intravenski Svinje: Intramuskularno
Cattle: Subcutaneous or Intravenous use Pigs: Intramuscular use
Goveda: subkutano ili intravenozno davanje Svinje: intrmuskularno davanje
Cattle: subcutaneous use, intravenous use.
Goveda: potkožno, u venu.
Catumaxomab + prednisolone (N=111)
Katumaksomab + prednizolon (N=111)
Catumaxomab was administered as four 3-hour constant-rate i.p. infusions in doses of 10, 20, 50 and 150 micrograms on day 0, 3, 7 and 10, respectively, in both groups.
Katumaksomab je primjenjen u četiri 3-satne i.p. infuzije konstantne brzine u dozama od 10, 20, 50 i 150 mikrograma na dan 0, 3, 7 i 10, kod obje skupine ispitanika.
Caucasian 34 %
Bijelci 34
cause hypoglycaemia.
transferaze]
cause mouth sores (oral ulcerations). weaken your immune system.
uzrokovati ranice u ustima (oralne ulceracije). oslabiti Vaš imunološki sustav.
caused an increased incidence of
incidencije gastrointestinalnih i jetrenih
caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs); caused by congenital (inborn) heart defects with shunts (abnormal passageways) causing abnormal flow of blood through the heart and lungs.
uzrokovan sklerodermom (također naziva sistemska skleroza, bolest u slučaju koje postoji abnormalan rast veznoga tkiva koji podržava kožu i ostale organe); uzrokovano kongenitalnim (urođenim) srčanim manama sa šantom (abnormalni prolazi) uzrokovani abnormalnim protokom krvi kroz srce i pluća.
caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs); caused by congenital (inborn) heart defects with shunts (abnormal passageways) causing abnormal flow of blood through the heart and lungs.
uzrokovana sklerodermijom (također nazvanom i sistemska skleroza, bolest s abnormalnim rastom vezivnog tkiva koje podržava kožu i druge organe); uzrokovana kongenitalnim (urođenim) srčanim greškama sa šantovima (abnormalnim prolazima) koji uzrokuju nenormalno protjecanje krvi kroz srce i pluća.
causes a similar increase in
Zbog inhibicijskog učinka
causes a similar increase in trazodone exposure.
Zbog inhibicijskog učinka
Causes of osteoporosis other than oestrogen deficiency and ageing should be considered.
Moraju se razmotriti i drugi uzroci osteoporoze osim nedostatka estrogena i starenja.
Caution - do not lift the pen off your injection site until the “clicking” sound stops and you see green ticks in the injection status window.
Oprez - nemojte dizati brizgalicu sa mjesta injiciranja sve dok ne prestane zvuk "klikanja" i dok ne vidite zelene kvačice u prozorčiću stanja injekcije.
Caution - do not recap the pen.
Oprez - nemojte vraćati zatvarač natrag na brizgalicu.
Caution - do not recap the Zinbryta pre- filled syringe.
Oprez - nemojte vraćati zatvarač natrag na Zinbryta napunjenu štrcaljku.
Caution - do not recap the Zinbryta pre-filled syringe.
Oprez - nemojte vraćati zatvarač natrag na Zinbryta napunjenu štrcaljku.
Caution - do not remove the cap until you are ready to inject.
Oprez – nemojte odstraniti zatvarač dok niste spremni injicirati.
Caution - do not touch or push down on the needle cover, you could get a needle injury.
Oprez - nemojte dirati ili pritiskati pokrov igle, možete se ozlijediti iglom.
CAUTION HIGH STRENGTH
OPREZ, VISOKA DOZA
Caution in prescribing to patients with a history of or risk factors for coronary heart disease
Da je potreban oprez u primjeni Tasigne u bolesnika s čimbenicima rizika za koronarnu bolest srca u anamnezi
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure)
Oprez kod primjene u starijih s obzirom na rizike povezane s dobi (osobito karcinom mokraćnog mjehura, prijelome i zatajenje srca).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Oprez kod primjene u starijih osoba s obzirom na rizike povezane s dobi (osobito karcinom mokraćnog mjehura, prijelome i zatajenje srca).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Oprez kod primjene u starijih s obzirom na rizike povezane s dobi (osobito karcinom mokraćnog mjehura, prijelome i zatajenje srca).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Oprez kod primjene u starijih s obzirom na rizike povezane s dobi (osobito karcinom mokraćnog mjehura, prijelome kostiju i zatajenje srca).
Caution is
Neophodan je oprez i
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se ARICLAIM primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina ili amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum), or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se ARICLAIM primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina ili amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if Cymbalta is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se Cymbalta primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if duloxetine is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St. John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se duloksetin primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if Duloxetine Lilly is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se Duloksetin Lilly primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if Duloxetine Mylan is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se Duloxetine Mylan primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if Xeristar is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se Xeristar primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina ili amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if YENTREVE is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se YENTREVE primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina ili amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advisable if YENTREVE is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MOAIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Preporučuje se oprez ako se YENTREVE primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina ili amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
Caution is advised and combination with these medicinal products should if possible be avoided.
Savjetuje se oprez, te treba izbjegavati kombinacije s ovim lijekovima, ako je to moguće.
Caution is advised and monitoring for adrenocortical insufficiency should occur if patients are withdrawn from prednisone or prednisolone.
Preporučuje se oprez i potreban je nadzor zbog moguće adrenokortikalne insuficijencije ako bolesnik prestane uzimati prednizon ili prednizolon.
Caution is advised as co-administration may increase the toxicity of Teysuno.
Preporučuje se oprez jer istodobna primjena nitroimidazola može povećati toksičnost lijeka Teysuno.
Caution is advised due to the possibility of an additive or potentiating effect with CNS depressants (e.g. alcohol, barbiturates, opiates, sedatives, or anaesthetics).
Preporuča se oprez zbog mogućeg aditivnog ili potencirajućeg učinka s depresorima središnjeg živčanog sustava (alkohol, barbiturati, opijati, sedativi ili anestetici).
Caution is advised during co- administration of posaconazole with CYP3A4 substrates administered intravenously and the dose of the CYP3A4 substrate may need to be reduced.
Savjetuje se oprez tijekom istodobne primjene posakonazola i supstrata CYP3A4 koji se primjenjuju intravenski, a možda će biti potrebno sniziti dozu supstrata CYP3A4.
Caution is advised during concomitant administration of EMEND and orally administered active substances that are metabolised primarily through CYP3A4 and with a narrow therapeutic range, such as cyclosporine, tacrolimus, sirolimus, everolimus, alfentanil, diergotamine, ergotamine, fentanyl, and quinidine (see section 4.4).
Preporučuje se oprez kad se EMEND primjenjuje zajedno s peroralno primjenjenim djelatnim tvarima koje se metaboliziraju prvenstveno putem CYP3A4 i imaju uski terapijski indeks, kao što su ciklosporin, takrolimus, sirolimus, everolimus, alfentanil, diergotamin, ergotamin, fentanil i kinidin (vidjeti dio 4.4).
Caution is advised if mirabegron is co-administered with medicinal products with a narrow therapeutic index and significantly metabolised by CYP2D6, such as thioridazine, Type 1C antiarrhythmics (e.g., flecainide, propafenone) and tricyclic antidepressants (e.g., imipramine, desipramine).
Savjetuje se oprez ako se mirabegron istodobno primjenjuje s lijekovima koji imaju uski terapijski indeks i kada se metaboliziraju pomoću CYP2D6, kao što su tioridazin, antiaritmici tipa 1C (npr. flekainid, propafenon) i triciklički antidepresivi (npr. imipramin, dezipramin).
Caution is advised if Tyverb is prescribed to patients with severe renal impairment (see sections 4.2 and 5.2).
Savjetuje se oprez pri primjeni lijeka Tyverb u bolesnika s teškim oštećenjem funkcije bubrega (vidjeti dijelove 4.2 i 5.2).
Caution is advised in case of combination with CYP3A4 substrates having a narrow therapeutic margin i.e. immunosuppressive agents (cyclosporine, tacrolimus, sirolimus) as well as CYP3A4- metabolised cytotoxics, i.e. cyclophosphamide, etoposide, finasteride, ifosfamide, tamoxifen, vinca- alcaloids.
Savjetuje se oprez u slučaju kombinacije sa supstratima CYP3A4 koji imaju uzak terapijski raspon, tj. imunosupresivima (ciklosporinom, takrolimusom, sirolimusom) kao i citotoksičnim lijekovima koje metabolizira CYP3A4, tj. ciklofosfamidom, etoposidom, finasteridom, ifosfamidom, tamoksifenom i vinka alkaloidima.
Caution is advised in case of severe hepatic impairment (see section 4.4).
U slučaju teškog oštećenja jetre preporučuje se oprez (vidjeti dio 4.4.4).
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g.
Savjetuje se oprez u bolesnica koje uzimaju antikoagulanse i/ili lijekove za koje se zna da utječu na funkciju trombocita (npr.
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g.
Savjetuje se oprez u bolesnika koji uzimaju antikoagulanse i/ili lijekove koji utječu na funkciju trombocita (npr.
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g.
Savjetuje se oprez u bolesnika koji uzimaju antikoagulanse i/ili lijekove za koje se zna da utječu na funkciju trombocita (npr.